Trial · NCT03681184
Results by group60
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 60
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change in 24-hour Urinary Oxalate Excretion Corrected for Body Surface Area (BSA) From Baseline to Month 6 | Placebo/Lumasiran | -11.8 | Standard Error 3.8 | percent change | |
| Percent Change in 24-hour Urinary Oxalate Excretion Corrected for Body Surface Area (BSA) From Baseline to Month 6 | Lumasiran/Lumasiran | -65.4 | Standard Error 2.9 | percent change | |
| Absolute Change in 24-hour Urinary Oxalate Corrected for BSA From Baseline to Month 6 | Placebo/Lumasiran | -0.27 | Standard Error 0.08 | mmol/24hr/1.73m^2 | |
| Absolute Change in 24-hour Urinary Oxalate Corrected for BSA From Baseline to Month 6 | Lumasiran/Lumasiran | -1.24 | Standard Error 0.06 | mmol/24hr/1.73m^2 | |
| Percent Change in 24-hour Urinary Oxalate:Creatinine Ratio From Baseline to Month 6 | Placebo/Lumasiran | -10.8 | Standard Error 5.4 | percent change | |
| Percent Change in 24-hour Urinary Oxalate:Creatinine Ratio From Baseline to Month 6 | Lumasiran/Lumasiran | -62.5 | Standard Error 4.0 | percent change | |
| Percentage of Participants With 24-hour Urinary Oxalate Level Corrected for BSA at or Below 1.5 x ULN at Month 6 | Placebo/Lumasiran | 0 | percentage of participants | ||
| Percentage of Participants With 24-hour Urinary Oxalate Level Corrected for BSA at or Below 1.5 x ULN at Month 6 | Lumasiran/Lumasiran | 84.0 | percentage of participants | ||
| Percentage of Participants With 24-hour Urinary Oxalate Level Corrected for BSA at or Below ULN at Month 6 | Placebo/Lumasiran | 0 | percentage of participants | ||
| Percentage of Participants With 24-hour Urinary Oxalate Level Corrected for BSA at or Below ULN at Month 6 | Lumasiran/Lumasiran | 52.0 | percentage of participants | ||
| Percentage Change in Plasma Oxalate From Baseline to Month 6 | Placebo/Lumasiran | -0.3 | Standard Error 4.3 | percent change | |
| Percentage Change in Plasma Oxalate From Baseline to Month 6 | Lumasiran/Lumasiran | -39.8 | Standard Error 2.9 | percent change | |
| Absolute Change in Plasma Oxalate From Baseline to Month 6 | Placebo/Lumasiran | 1.3 | Standard Error 1.1 | μmol/L | |
| Absolute Change in Plasma Oxalate From Baseline to Month 6 | Lumasiran/Lumasiran | -7.5 | Standard Error 0.8 | μmol/L | |
| Change in Estimated Glomerular Filtration Rate (eGFR) From Baseline to Week 2 and Months 1, 2, 3, 4, 5 and 6 | Placebo/Lumasiran | Week 2 | -5 | Standard Deviation 9 | mL/min/1.73m^2 |
| Change in Estimated Glomerular Filtration Rate (eGFR) From Baseline to Week 2 and Months 1, 2, 3, 4, 5 and 6 | Lumasiran/Lumasiran | Week 2 | -4 | Standard Deviation 9 | mL/min/1.73m^2 |
| Change in Estimated Glomerular Filtration Rate (eGFR) From Baseline to Week 2 and Months 1, 2, 3, 4, 5 and 6 | Placebo/Lumasiran | Month 1 | -6 | Standard Deviation 7 | mL/min/1.73m^2 |
| Change in Estimated Glomerular Filtration Rate (eGFR) From Baseline to Week 2 and Months 1, 2, 3, 4, 5 and 6 | Lumasiran/Lumasiran | Month 1 | -2 | Standard Deviation 12 | mL/min/1.73m^2 |
| Change in Estimated Glomerular Filtration Rate (eGFR) From Baseline to Week 2 and Months 1, 2, 3, 4, 5 and 6 | Placebo/Lumasiran | Month 2 | -5 | Standard Deviation 8 | mL/min/1.73m^2 |
| Change in Estimated Glomerular Filtration Rate (eGFR) From Baseline to Week 2 and Months 1, 2, 3, 4, 5 and 6 | Lumasiran/Lumasiran | Month 2 | -2 | Standard Deviation 15 | mL/min/1.73m^2 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03681184/results